Raphael Mechoulam's group at the Hebrew University of Jerusalem reported isolating 2-arachidonoylglycerol, or 2-AG, from the canine gut and characterised its effects, while a group at Teikyo University reported its affinity for the cannabinoid receptors. The compound was already known to chemists; that it occurs in mammals and acts on these receptors was new.[1]
In the cultural atlas
References
Checked. The date and the event were compared with a source that was read.
